Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Dividends Paid - Common (2023)

Historic Dividends Paid - Common for Gyre Therapeutics (GYRE) over the last 1 years, with Q3 2023 value amounting to $1.5 million.

  • Gyre Therapeutics' Dividends Paid - Common changed N/A to $1.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $12.8 million, marking a year-over-year change of. This contributed to the annual value of $45.0 million for FY2022, which is N/A changed from last year.
  • Per Gyre Therapeutics' latest filing, its Dividends Paid - Common stood at $1.5 million for Q3 2023.
  • In the past 5 years, Gyre Therapeutics' Dividends Paid - Common ranged from a high of $7.8 million in Q1 2023 and a low of $1.5 million during Q3 2023